Comment on

• Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.

  Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I, Greenberg H, Hall WJ, McNitt S, Zareba W, Solomon S, Steinberg JS; MADIT-CRT Executive Committee. Arshad A, et al. J Am Coll Cardiol. 2011 Feb 15;57(7):813-20. doi: 10.1016/j.jacc.2010.06.061. J Am Coll Cardiol. 2011. PMID: 21310317 Clinical Trial.
• Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

  Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Iles L, et al. J Am Coll Cardiol. 2011 Feb 15;57(7):821-8. doi: 10.1016/j.jacc.2010.06.062. J Am Coll Cardiol. 2011. PMID: 21310318